Alteration of Cyclin D1 in Chinese Patients with Breast Carcinoma and its Correlation with Ki-67, pRb, and p53

Archives of Medical Research

Volumn 38, Issue 8, 2007, Pages 846-852

  Guo, Ling Ling ^b   Gao, Peng ^a   Wu, Ya Guang ^c   Jian, Wen Cheng ^d   Hao, Chun Yan ^a   Li, Hong ^a   Lin, Xiao yan ^c  

^a SHANDONG UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

^c SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^d Key Laboratory of Cardiovascular Proteomics of Shandong Province   (China)

Author keywords

Breast carcinoma; Cyclin; Prognosis

Indexed keywords

CYCLIN D1; KI 67 ANTIGEN; PROTEIN P53;

ADULT; ARTICLE; BREAST CARCINOMA; CARCINOGENESIS; CHINESE; CONTROLLED STUDY; GENE AMPLIFICATION; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MUTATION; PROGNOSIS; PROTEIN EXPRESSION; RB GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; TUMOR SUPPRESSOR GENE;

ADULT; AGE DISTRIBUTION; BLOTTING, SOUTHERN; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CHINA; CYCLIN D1; FEMALE; FOLLOW-UP STUDIES; GENE AMPLIFICATION; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; RETINOBLASTOMA PROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL RATE; TIME FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 34848895198     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2007.06.004     Document Type: Article

References (33)

1. Lam W.W., Fielding R., and Ho E.Y. Predicting psychological morbidity in Chinese women after surgery for breast carcinoma. Cancer 103 (2005) 637-646
2. Luini A., Gatti G., Ballardini B., Zurrida S., Galimberti V., Veronesi P., et al. Development of axillary surgery in breast cancer. Ann Oncol 16 (2005) 259-262
3. Rafferty M.A., Fenton J.E., and Jones A.S. An overview of the role and inter-relationship of epidermal growth factor receptor, cyclin D and retinoblastoma protein on the carcinogenesis of squamous cell carcinoma of the larynx. Clin Otolaryngol 26 (2001) 317-320
4. Sabah M., Cummins R., Leader M., and Kay E. Altered expression of cell cycle regulatory proteins in gastrointestinal stromal tumors: markers with potential prognostic implications. Hum Pathol 37 (2006) 648-655
5. Jin M., Inoue S., Umemura T., Moriya J., Arakawa M., Nagashima K., et al. Cyclin D1, p16 and retinoblastoma gene product expression as a predictor for prognosis in non-small cell lung cancer at stages I and II. Lung Cancer 34 (2001) 207-218
6. Carlos de Vicente J., Herrero-Zapatero A., Fresno M.F., and Lopez-Arranz J.S. Expression of cyclin D1 and Ki-67 in squamous cell carcinoma of the oral cavity: clinicopathological and prognostic significance. Oral Oncol 38 (2002) 301-308
7. Shariat S.F., Ashfaq R., Sagalowsky A.I., and Lotan Y. Correlation of cyclin D1 and E1 expression with bladder cancer presence, invasion, progression, and metastasis. Hum Pathol 37 (2006) 1568-1576
8. Bartkova J., Lukas J., Muller H., Lutzhoft D., Strauss M., and Bartek J. Cyclin D protein expression and function in human breast cancer. Int J Cancer 57 (1994) 353-361
9. Gillett C.E., Smith P., Gregory W.M., Richards M., Millis R., Peters G., et al. Cyclin Dl and prognosis in breast cancer. Int J Cancer (Pred Oncol) 69 (1996) 92-99
10. Michalides R., Hageman P., Van Tinteren H., Houben L., Wientjens E., Klompaker R., et al. A clinicopathological study on overexpression of cyclin Dl and of p53 in a series of 248 patients with operable breast cancer. Br J Cancer 73 (1996) 728-734
11. McIntosh G.G., Anderson J.J., Milton I., Steward M., Parr A.H., Thomas M.D., et al. Determination of the prognostic value of cyclin Dl overexpression in breast cancer. Oncogene 11 (1995) 885-891
12. Umekita Y., Ohi Y., Sagara Y., and Yoshida H. Overexpression of cyclinD1 predicts for poor prognosis in estrogen receptor-negative breast cancer patients. Int J Cancer 98 (2002) 415-418
13. Simpson J.F., Quan D.E., O'Malley F., Odom-Maryon T., and Clarke P.E. Amplification of CCND1 and expression of its protein product, cyclin D1, in ductal carcinoma in situ of the breast. Am J Pathol 151 (1997) 161-168
14. Sugimachi K., Aishima S., Taguchi K., Tanaka S., Shimada M., Kajiyama K., et al. The role of overexpression and gene amplification of cyclin D1 in intrahepatic cholangiocarcinoma. J Hepatol 35 (2001) 74-79
15. Kyomoto R., Kumazawa H., Toda Y., Sakaida N., Okamura A., Iwanaga M., et al. Cyclin-D1-gene amplification is a more potent prognostic factor than its protein over-expression in human head-and-neck squamous-cell carcinoma. Int J Cancer 74 (1997) 576-581
16. Gao P., Zhou G.Y., Yin G., Liu Y., Liu Z.Y., Zhang J., et al. Lymphatic vessel density as a prognostic indicator for patients with stage I cervical carcinoma. Hum Pathol 37 (2006) 719-725
17. Papantoniou V.J., Souvatzoglou M.A., Valotassiou V.J., Ambela C., Koutsikos J., Lazaris D., Christodoulidou J.K., et al. Relationship of cell proliferation (Ki-67) to 99mTc-(V)DMSA uptake in breast cancer. Breast Cancer Res 6 (2004) 56-62
18. Khan A.A., Abel P.D., Chaudhary K.S., Gulzar Z., Stamp G.W., and Lalani E.N. Inverse correlation between high level expression of cyclin E and proliferation index in transitional cell carcinoma of the bladder. Mol Pathol 56 (2003) 353-361
19. Palmqvist R., Stenling R., Oberg A., and Landberg G. Expression of cyclin D1 and retinoblastoma protein in colorectal cancer. Eur J Cancer 34 (1998) 1575-1581
20. de Jong J.S., van Diest P.J., Michalides R.J., van der Valk P., Meijer C.J., and Baak J.P. Correlation of cyclin D1 and Rb gene expression with apoptosis in invasive breast cancer. Mol Pathol 51 (1998) 30-34
21. Tiezzi D.G., Andrade J.M., Ribeiro-Silva A., Zola F.E., Marana H.R., and Tiezzi M.G. HER-2, p53, p21 and hormonal receptors proteins expression as predictive factors of response and prognosis in locally advanced breast cancer treated with neoadjuvant docetaxel plus epirubicin combination. BMC Cancer 7 (2007) 36
22. Yamashita H., Toyama T., Nishio M., Ando Y., Hamaguchi M., Zhang Z., et al. p53 protein accumulation predicts resistance to endocrine therapy and decreased post-relapse survival in metastatic breast cancer. Breast Cancer Res 8 (2006) R48
23. Pruneri G., Carboni N., Baldini L., Intini D., Colombi M., Bertolini F., et al. Cell cycle regulators in multiple myeloma: prognostic implications of p53 nuclear accumulation. Hum Pathol 34 (2003) 41-47
24. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162 (1987) 156-159
25. Wan Q.H., Qian K.X., and Fang S.G. A simple DNA extraction and rapid specific identification technique for single cells and early embryos of two breeds of Bos taurus. Anim Reprod Sci 77 (2003) 1-9
26. Renedo M., Martinez-Delgado B., Arranz E., Garcia M., Urioste M., Martinez-Ramirez A., et al. Chromosomal changes pattern and gene amplification in T cell non-Hodgkin's lymphomas. Leukemia 15 (2001) 1627-1632
27. Zhu X.L., Hartwick W., Rohan T., and Kandel R. Cyclin D1 gene amplification and protein expression in benign breast disease and breast carcinoma. Mod Pathol 11 (1998) 1082-1088
28. Dublin E.A., Patel N.K., Gillett C.E., Smith P., and Barnes D.M. p53 immunohistochemical staining and survival after adjuvant chemotherapy for breast cancer. Int J Cancer 74 (1997) 605-608
29. Steele R.J., and Lane D.P. p53 in cancer: a paradigm for modern management of cancer. Surgeon 3 (2005) 197-205
30. Jones B.A., Kasl S.V., Howe C.L., Lachman M., Dubrow R., Curnen M.M., et al. African-American/White differences in breast carcinoma: p53 alterations and other tumor characteristics. Cancer 101 (2004) 1293-1301
31. Steeg P.S., and Zhou Q. Cyclins and breast cancer. Breast Cancer Res Treat 52 (1998) 17-28
32. Sheyn I., Noffsinger A.E., Heffelfinger S., Davis B., Miller M.A., and Fenoglio-Preiser C.M. Amplification and expression of the cyclin D1 gene in anal and esophageal squamous cell carcinomas. Hum Pathol 28 (1997) 270-276
33. Yang W.I., Zukerberg L.R., Motokura T., Arnold A., and Harris N.L. Cyclin D1 (Bcl-1, PRAD1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia. Am J Pathol 145 (1994) 86-96